IMPACT OF 5-FU ON THE STRUCTURE OF THE U4-U6 COMPLEX
5-FU 对 U4-U6 复合物结构的影响
基本信息
- 批准号:2101357
- 负责人:
- 金额:$ 10.45万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1993
- 资助国家:美国
- 起止时间:1993-07-16 至 1998-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The clinically important anti-tumor agent 5-fluorouracil (5-FU) was
designed to inhibit thymidylate synthase (TS). The potent inhibition of TS
is an important aspect of the efficacy of 5-FU, but there is longstanding
and growing evidence that 5-FU interferes with ribonucleic acid (RNA)
mediated processes, particularly the splicing of precursor messenger RNA
(pre-mRNA). It is possible that RNA directed actions of 5-FU constitute a
major portion of its potency. The excision of intervening sequences and
splicing of exons takes place in the spliceosome - a complex of small
nuclear RNAs (snRNA) and associated proteins. Duplexes composed of single
stranded regions of two or more different types of snRNA occur upon
formation of the spliceosome. This association between snRNAs is based
upon base pairing of complementary regions and is required for proper
splicing of the pre-mRNA. These duplexes contain guanosme-uridine (GU)
and uridine-uridine (UU) wobble base pairs in addition to guanosine-
cytidine (GC) and adenosine-uridine (AU) base pairs. Fluorine substitution
at C5 of U may impact the relative stability of wobble and normal base
pairs and alter the binding stability of snRNA complexes containing 5-FU.
The structural consequences of 5-FU incorporation into RNA are not well
understood at present and the proposed analysis of RNA containing 5-FU by
nuclear magnetic resonance (NMR) spectroscopy will contribute to our
knowledge of the RNA directed mechanisms of potency and toxicity of this
drug. This proposal aims to incorporate 5-fluorouridine into RNA oligomers
using solution and solid-phase chemistries. A detailed model of the U4-U6
snRNA complex is developed based upon NMR spectroscopic data. The two stem
regions formed by the interaction of human U4 and U6 snRNAs are studied in
detail by using 1H NMR spectroscopy. The impact of 5-fluorouridine
substitution for each uridine is assessed thermodynamically. Duplexes
with anomalous melting profiles are studied in detail by using 1H NMR
spectroscopy. A portion of the U4-U6 snRNA complex is prepared by using an
in vitro T7 RNA polymerase transcription system. Isotopically enriched
nucleoside triphosphate (NTP) is incorporated into the U4-U6 snRNA
complex, which is then analyzed by 1H-13C and 1H-15N NMR spectroscopy. The
overall impact of 5-FU incorporation on the U4-U6 snRNA complex is
evaluated spectroscopically. Understanding the structural basis for the
RNA mediated potency and toxicity of 5-FU will ald in the development of
future anticancer strategies that rationally intervene in pre-mRNA
splicing, or other RNA mediated cellular processes.
临床上重要的抗肿瘤药物5-氟尿嘧啶(5-FU)是
旨在抑制胸苷酸合酶(TS)。强效抑制TS
是5-FU疗效的一个重要方面,但长期以来存在
越来越多的证据表明 5-FU 会干扰核糖核酸 (RNA)
介导的过程,特别是前体信使RNA的剪接
(前mRNA)。 5-FU 的 RNA 定向作用可能构成
其效力的主要部分。干扰序列的切除和
外显子的剪接发生在剪接体中——剪接体是一个小分子的复合体
核 RNA (snRNA) 和相关蛋白。复式公寓由单层公寓组成
两种或多种不同类型 snRNA 的绞合区发生在
剪接体的形成。 snRNA 之间的这种关联是基于
基于互补区域的碱基配对,并且是正确的
前体 mRNA 的剪接。 这些双链体含有鸟苷-尿苷 (GU)
除了鸟苷之外,还有尿苷-尿苷 (UU) 摆动碱基对
胞苷 (GC) 和腺苷-尿苷 (AU) 碱基对。氟取代
U的C5处可能会影响摆动和正常底座的相对稳定性
配对并改变含有 5-FU 的 snRNA 复合物的结合稳定性。
5-FU 掺入 RNA 的结构后果并不理想
目前的理解和建议的含有 5-FU 的 RNA 分析
核磁共振(NMR)光谱将有助于我们
RNA 指导的效力和毒性机制的知识
药品。该提案旨在将 5-氟尿苷掺入 RNA 寡聚物中
使用溶液和固相化学。 U4-U6的详细模型
snRNA 复合物是根据 NMR 光谱数据开发的。两个茎
研究了人类 U4 和 U6 snRNA 相互作用形成的区域
通过使用 1H NMR 光谱进行详细分析。 5-氟尿苷的影响
通过热力学评估每个尿苷的取代。 复式公寓
使用 1H NMR 详细研究了具有异常熔化曲线的物质
光谱学。 U4-U6 snRNA 复合物的一部分是通过使用
体外 T7 RNA 聚合酶转录系统。同位素富集
三磷酸核苷 (NTP) 掺入 U4-U6 snRNA 中
络合物,然后通过 1H-13C 和 1H-15N NMR 光谱进行分析。这
5-FU 掺入对 U4-U6 snRNA 复合物的总体影响是
通过光谱评估。 了解结构基础
RNA 介导的 5-FU 的效力和毒性将有助于开发
合理干预前体mRNA的未来抗癌策略
剪接或其他 RNA 介导的细胞过程。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
William H Gmeiner其他文献
William H Gmeiner的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('William H Gmeiner', 18)}}的其他基金
Improved Treatment of Colorectal Cancer with CF10
CF10 改善结直肠癌治疗
- 批准号:
10698394 - 财政年份:2023
- 资助金额:
$ 10.45万 - 项目类别:
Nanodelivery of FP polymers to improve treatment of metastatic colorectal cancer
FP 聚合物的纳米递送可改善转移性结直肠癌的治疗
- 批准号:
10734188 - 财政年份:2023
- 资助金额:
$ 10.45万 - 项目类别:
Improved Treatment of Colorectal Cancer with CF10 Diversity Supplement
使用 CF10 多样性补充剂改善结直肠癌的治疗
- 批准号:
10543218 - 财政年份:2022
- 资助金额:
$ 10.45万 - 项目类别:
Improved Treatment of Colorectal Cancer with CF10
CF10 改善结直肠癌治疗
- 批准号:
10254547 - 财政年份:2021
- 资助金额:
$ 10.45万 - 项目类别:
REGULATION OF NON RECEPTOR PTK ACTIVITY BY SH3 DOMAINS
SH3 结构域对非受体 PTK 活性的调节
- 批准号:
6120940 - 财政年份:1999
- 资助金额:
$ 10.45万 - 项目类别:
相似海外基金
Mechanisms of messenger RNA splicing and RNA processing regulation
信使RNA剪接和RNA加工调控机制
- 批准号:
10623834 - 财政年份:2023
- 资助金额:
$ 10.45万 - 项目类别:
Collaborative Research: Connecting the sequence logic of RNA splicing to nuclear localization
合作研究:将 RNA 剪接的序列逻辑与核定位联系起来
- 批准号:
2246530 - 财政年份:2023
- 资助金额:
$ 10.45万 - 项目类别:
Standard Grant
Collaborative Research: Connecting the sequence logic of RNA splicing to nuclear localization
合作研究:将 RNA 剪接的序列逻辑与核定位联系起来
- 批准号:
2246531 - 财政年份:2023
- 资助金额:
$ 10.45万 - 项目类别:
Standard Grant
Analysis on how RNA splicing factors change global gene expression patterns and regulate male fertility.
分析RNA剪接因子如何改变全局基因表达模式并调节男性生育能力。
- 批准号:
2882792 - 财政年份:2023
- 资助金额:
$ 10.45万 - 项目类别:
Studentship
Aberrant RNA splicing in sporadic inclusion body myositis
散发性包涵体肌炎中的异常RNA剪接
- 批准号:
23K18260 - 财政年份:2023
- 资助金额:
$ 10.45万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Synthetic introns for selective targeting of RNA splicing factor-mutant leukemia
用于选择性靶向RNA剪接因子突变型白血病的合成内含子
- 批准号:
10722782 - 财政年份:2023
- 资助金额:
$ 10.45万 - 项目类别:
Cancer immune therapeutics targeting aberrant RNA splicing products
针对异常 RNA 剪接产物的癌症免疫疗法
- 批准号:
23H02688 - 财政年份:2023
- 资助金额:
$ 10.45万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
RNA splicing regulation during alcohol withdrawal
酒精戒断过程中的 RNA 剪接调节
- 批准号:
10785159 - 财政年份:2023
- 资助金额:
$ 10.45万 - 项目类别:
Targeting Dysregulated RNA Splicing in Neurodegenerative Diseases
靶向神经退行性疾病中失调的 RNA 剪接
- 批准号:
10729566 - 财政年份:2023
- 资助金额:
$ 10.45万 - 项目类别:
Srsf3-mediated alternative RNA splicing in craniofacial development
Srsf3介导的颅面发育中的选择性RNA剪接
- 批准号:
10650417 - 财政年份:2022
- 资助金额:
$ 10.45万 - 项目类别:














{{item.name}}会员




